CDC panel recommends Pfizer Covid vaccine for people 16 years and older, clearing pivotal hurdle

Health, Fitness & Food

CDC headquarters in Atlanta

Elijah Nouvelage | Bloomberg via Getty Images

A key U.S. Centers for Disease Control and Prevention panel voted unanimously to recommend PfizerBioNTech‘s Covid-19 vaccine for people 16 years and older on Saturday, clearing another pivotal hurdle for the drug before vaccinations begin in the coming days.

The CDC’s Advisory Committee on Immunization Practices, an outside group of medical experts that advises the agency, voted 11 to 0 recommend the vaccine for use in people 16 and older under the Food and Drug Administrations emergency authorization. Three members recused themselves due to conflicts.

On Dec. 1, the group voted 13-1 to give health-care workers and long-term care facility residents the first vaccine doses once cleared for public use. The ACIP’s emergency meeting, which was pushed from Sunday to Saturday, followed the FDA’s decision to issue Pfizer’s vaccine an emergency use authorization Friday evening.

This is a developing story. Please check back later for updates.

Products You May Like

Articles You May Like

As U.S. Covid cases stall, top health officials warn variants could ‘hijack’ nation’s progress
Nike Has So Many New Pieces For Spring, We’re Already Planning Extra Workouts
Rare Disease Day: Raising Awareness for Rare Cancers
New tool identifies security and privacy risks associated with COVID-19 contact tracing apps
Cincinnati Children’s scientists receive grant to advance research on air pollution and mental health

Leave a Reply

Your email address will not be published. Required fields are marked *